Engineering cells with active-ingredient-loaded
micro/nanoparticles
is becoming increasingly popular for imaging and therapeutic applications.
A critical yet inadequately addressed issue during its implementation
concerns the significant number of particles that remain unbound following
the engineering process, which inadvertently generate signals and
impart transformative effects onto neighboring nontarget cells. Here
we demonstrate that those unbound micro/nanoparticles remaining in
solution can be efficiently separated from the particle-labeled cells
by implementing a fast, continuous, and high-throughput Dean flow
fractionation (DFF) microfluidic device. As proof-of-concept, we applied
the DFF microfluidic device for buffer exchange to sort labeled suspension
cells (THP-1) from unbound fluorescent dye and dye-loaded micro/nanoparticles.
Compared to conventional centrifugation, the depletion efficiency
of free dyes or particles was improved 20-fold and the mislabeling
of nontarget bystander cells by free particles was minimized. The
microfluidic device was adapted to further accommodate heterogeneous-sized
mesenchymal stem cells (MSCs). Complete removal of unbound nanoparticles
using DFF led to the usage of engineered MSCs without exerting off-target
transformative effects on the functional properties of neighboring
endothelial cells. Apart from its effectiveness in removing free particles,
this strategy is also efficient and scalable. It could continuously
process cell solutions with concentrations up to 10<sup>7</sup> cells·mL<sup>–1</sup> (cell densities commonly encountered during cell
therapy) without observable loss of performance. Successful implementation
of this technology is expected to pave the way for interference-free
clinical application of micro/nanoparticle engineered cells